Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study
- PMID: 27437997
- PMCID: PMC4954688
- DOI: 10.1371/journal.pone.0159071
Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study
Abstract
Aims: The control of blood glucose levels, blood pressure (BP), and low-density lipoprotein cholesterol (LDL-C) levels reduces the risk of diabetes complications; however, data are scarce on control status of these factors among workers with diabetes. The present study aimed to estimate the prevalence of participants with diabetes who meet glycated hemoglobin (HbA1c), BP, and LDL-C recommendations, and to investigate correlates of poor glycemic control in a large working population in Japan.
Methods: The Japan Epidemiology Collaboration on Occupational Health (J-ECOH) Study is an ongoing cohort investigation, consisting mainly of employees in large manufacturing companies. We conducted a cross-sectional analysis of 3,070 employees with diabetes (2,854 men and 216 women) aged 20-69 years who attended periodic health examinations. BP was measured and recorded using different company protocols. Risk factor targets were defined using both American Diabetes Association (ADA) guidelines (HbA1c < 7.0%, BP < 140/90 mmHg, and LDL-C < 100 mg/dL) and Japan Diabetes Society (JDS) guidelines (HbA1c < 7.0%, BP < 130/80 mmHg, and LDL-C < 120 mg/dL). Logistic regression models were used to explore correlates of poor glycemic control (defined as HbA1c ≥ 8.0%).
Results: The percentages of participants who met ADA (and JDS) targets were 44.9% (44.9%) for HbA1c, 76.6% (36.3%) for BP, 27.1% (56.2%) for LDL-C, and 11.2% (10.8%) for simultaneous control of all three risk factors. Younger age, obesity, smoking, and uncontrolled dyslipidemia were associated with poor glycemic control. The adjusted odds ratio of poor glycemic control was 0.58 (95% confidence interval, 0.46-0.73) for participants with treated but uncontrolled hypertension, and 0.47 (0.33-0.66) for participants with treated and controlled hypertension, as compared with participants without hypertension. There was no significant difference in HbA1c levels between participants with treated but uncontrolled hypertension and those with treated and controlled hypertension.
Conclusion: Data from a large working population, predominantly composed of men, suggest that achievement of HbA1c, BP, and LDL-C targets was less than optimal, especially in younger participants. Uncontrolled dyslipidemia was associated with poor glycemic control. Participants not receiving antihypertensive treatment had higher HbA1c levels.
Conflict of interest statement
Similar articles
-
Achievement of national clinical practice recommendations among those in the Puerto Rican population with diabetes mellitus.P R Health Sci J. 2014 Dec;33(4):157-62. P R Health Sci J. 2014. PMID: 25563032
-
Associations of patient knowledge with drug-modifiable cardiovascular risk factor control in coronary artery disease patients with and without diabetes mellitus: results from the cross-sectional KNOW-ABC study.BMC Cardiovasc Disord. 2025 Mar 5;25(1):148. doi: 10.1186/s12872-025-04599-7. BMC Cardiovasc Disord. 2025. PMID: 40045198 Free PMC article.
-
A retrospective, cross-sectional study of real-world values of cardiovascular risk factors using a healthcare database in Japan.BMC Cardiovasc Disord. 2014 Sep 17;14:120. doi: 10.1186/1471-2261-14-120. BMC Cardiovasc Disord. 2014. PMID: 25231128 Free PMC article.
-
Glycaemic, blood pressure and cholesterol control in 25 629 diabetics.Cardiovasc J Afr. 2015 Jul-Aug;26(4):188-92. doi: 10.5830/CVJA-2015-050. Cardiovasc J Afr. 2015. PMID: 26407221 Free PMC article. Review.
-
Effects of glucose-lowering on outcome incidence in diabetes mellitus and the modulating role of blood pressure and other clinical variables: overview, meta-analysis of randomized trials.J Hypertens. 2019 Oct;37(10):1939-1949. doi: 10.1097/HJH.0000000000002152. J Hypertens. 2019. PMID: 31157748 Review.
Cited by
-
Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus.Diabetes Metab Syndr Obes. 2018 Oct 17;11:647-658. doi: 10.2147/DMSO.S176749. eCollection 2018. Diabetes Metab Syndr Obes. 2018. PMID: 30410377 Free PMC article.
-
Women are less likely than men to achieve optimal glycemic control after 1 year of treatment: A multi-level analysis of a Korean primary care cohort.PLoS One. 2018 May 2;13(5):e0196719. doi: 10.1371/journal.pone.0196719. eCollection 2018. PLoS One. 2018. PMID: 29718952 Free PMC article.
-
Substance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination.Curr Diab Rep. 2017 Jan;17(1):2. doi: 10.1007/s11892-017-0832-0. Curr Diab Rep. 2017. PMID: 28101793 Review.
-
Preoperative contributing factors and the remission of diabetes after metabolic surgery: the mediating role of preoperative triglyceride.Eat Weight Disord. 2024 Mar 4;29(1):18. doi: 10.1007/s40519-024-01647-7. Eat Weight Disord. 2024. PMID: 38436759 Free PMC article.
-
Mycobacterial Growth Inhibition Assay (MGIA) as a Host Directed Diagnostic Tool for the Evaluation of the Immune Response in Subjects Living With Type 2 Diabetes Mellitus.Front Cell Infect Microbiol. 2021 May 18;11:640707. doi: 10.3389/fcimb.2021.640707. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34084753 Free PMC article.
References
-
- International Diabetes Federation. IDF Diabetes Atlas, 6 ed. Brussels, Belgium: International Diabetes Federation, 2013.
-
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53. - PubMed
-
- Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755–62. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous